Blog
Theradaptive Treats First Patient in RESTORE Feasibility Study Evaluating OsteoAdapt™ DE in Dental Procedures
FREDERICK, Md., Aug. 26, 2025 /PRNewswire/ — Theradaptive, Inc., a clinical-stage biotechnology company pioneering targeted protein therapeutics for tissue regeneration, today announced that the first patient has been successfully treated in the RESTORE International … Read more
BioEvanesce: Pioneering Solutions for Post-Surgical Scar Tissue Adhesions
In June 2024, BioEvanesce established its laboratory at FITCI, Frederick’s leading incubator for life sciences and technology startups. The company is on a mission to tackle a pervasive and often overlooked post-surgical … Read more
Theradaptive Grows Again; Celebrates Ribbon-Cutting
September 19, 2024 – Founded in 2016, FITCI Grad Theradaptive is growing again. The company is commercializing a pipeline of therapeutics in the orthopedic space, targeting multiple clinical applications, including … Read more
Veralox Therapeutics Announces EMA Orphan Drug Designation for VLX-1005
— Receives New Designation for Treatment of Platelet-Activating Anti-Platelet Factor 4 (PF4) Disorders — Complements FDA Orphan Drug Designation and Fast Track Designation for VLX-1005 Source: Veralox Frederick, MD, Aug. … Read more
Partner Spotlight: InfoPathways – Allies and Advocates for Human IT
Exploring InfoPathways and their remarkable support of FITCI and the entrepreneurs we serve! This partnership, sparked by a referral, has blossomed into a powerful alliance, showcasing InfoPathways’ unwavering commitment to … Read more
AI and Robotics: How Startups Can Harness Technology for Growth
By Anna Eyler In a rapidly evolving business landscape, startups that don’t consider implementing emerging technologies like artificial intelligence (AI) and robotics into their operations are at risk of being … Read more
